Q32 Bio (QTTB) Consolidated Net Income (2017 - 2026)

Q32 Bio's Consolidated Net Income history runs 10 years deep, the most recent figure standing at -$7.7 million for Q1 2026.

• In Q1 2026, Consolidated Net Income rose 30.0% year-over-year to -$7.7 million; the TTM figure through Mar 2026 stood at $33.1 million (up 156.78% YoY), while the FY2025 annual figure was $29.8 million, up 164.68% from the prior year.
• Consolidated Net Income was -$7.7 million for Q1 2026 at Q32 Bio, down from $57.7 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $92.7 million in Q1 2022 to a low of -$34.6 million in Q4 2022.
• Historically, Consolidated Net Income has averaged -$4.7 million across 5 years, with a median of -$11.0 million in 2025.
• The sharpest annual moves came in 2022 and 2025: Consolidated Net Income surged 8735.88% in 2022, then tumbled 1015.44% in 2025.
• A 5-year view of Consolidated Net Income shows it stood at -$34.6 million in 2022, then increased by 21.52% to -$27.1 million in 2023, then soared by 47.7% to -$14.2 million in 2024, then soared by 506.86% to $57.7 million in 2025, then sank by 113.38% to -$7.7 million in 2026.
• The last three Consolidated Net Income figures came in at -$7.7 million (Q1 2026), $57.7 million (Q4 2025), and -$7.4 million (Q3 2025), per Business Quant data.